14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
ADRX vs MEDI: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
MEDI Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–1 Matrix Metrics)
MEDI Overall Winner
6-Pillar Tally: ADRX 0 – 0 MEDI (6 Tie)
Matrix Metrics: ADRX 1 – 2 MEDI
As of Nov 16, 2026, Harbor Health Care ETF (MEDI) is the stronger overall head-to-head candidate over ADRX (ADRX) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). ADRX carries a Unified Composite Score of 47.9/100 (HOLD) at $14.00 (N/M Forward P/E, N/A operating margin), whereas MEDI carries 42.1/100 (HOLD) at $35.59 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While ADRX currently prints a higher short-term Unified Composite Score (47.9/100 HOLD vs. MEDI 42.1/100 HOLD), MEDI captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ADRX vs MEDI. Trailing 12-month operating profitability (ADRX N/A vs MEDI N/A) and valuation multiples (ADRX N/M vs MEDI N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
MEDI Moat ProfileCyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ ADRX vs MEDI Key Questions & Quantitative Answers
As of Nov 16, 2026, Harbor Health Care ETF (MEDI) is the stronger overall head-to-head candidate over ADRX (ADRX) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). ADRX carries a Unified Composite Score of 47.9/100 (HOLD) at $14.00 (N/M Forward P/E, N/A operating margin), whereas MEDI carries 42.1/100 (HOLD) at $35.59 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While ADRX currently prints a higher short-term Unified Composite Score (47.9/100 HOLD vs. MEDI 42.1/100 HOLD), MEDI captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).
ADRX and MEDI split Growth & Scale metrics: ADRX posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with MEDI at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, ADRX generates N/A in USD-normalized revenue versus N/A for MEDI. In operating R&D and SG&A reinvestment, ADRX deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for MEDI.
ADRX and MEDI trade at balanced relative valuation multiples. ADRX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas MEDI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ADRX (N/A ROE) versus MEDI (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, ADRX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.05β · 76% Vol realized risk). By comparison, MEDI carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.59β · 22% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.